Prilocaine offers a significantly greater duration and safety margin without a vasopressor. Hence, addition of epinephrine is not necessary to prolong the duration of action, which can be an advantage when epinephrine is contraindicated.

Gufic BioSciences is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The company's standalone net profit declined 10.6% to Rs 18.11 crore on 6.7% increase in net sales to Rs 173.04 crore in Q4 FY23 over Q4 FY22.